NanoLogix, Inc. (PINKSHEETS:
NNLX) announces that the company has recently filed BNP™ (BioNanoPore)
national patent applications in China, Japan, India, Brazil, Russia and the
EU. These applications were filed in order to obtain intellectual property protection
for the company's technology in countries viewed as representing the largest
potential international market for BNP rapid detection, a revolutionary sandwiched-membrane
Petri-based technology that can reduce microorganism detection times by 100-400%.
At the company's September 25th shareholder meeting, the support for all proposals
presented by the company for shareholder approval was overwhelmingly positive,
with all shareholder-rights/takeover-defense plan proposals receiving 98-99%
of the 64 million shares voted out of roughly 101 million shares outstanding.
The company has reclaimed full rights to 18 patents previously licensed to
Nutra Pharma Corporation after failure of Nutra Pharma to pay the balance of
patent royalties due for 2008 and the first half of 2009. Nutra Pharma was served
notice of their default in July. NanoLogix has returned the 18 patents to the
company portfolio and will pursue development and marketing of select technological
aspects of the patents.
NanoLogix's April press release: "New Weapon in BioDefense Research: NanoLogix
Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague," was highlighted
in the latest issue of the Department of Defense Quarterly, "CBRNIAC,"
from the Chemical, Biological, Radiological and Nuclear Defense Information
Analysis Center. The publication can be accessed at: https://www.cbrniac.apgea.army.mil/Products/Newsletter/Pages/default.aspx
NanoLogix has received notification from New Brunswick Scientific of a November
20th shipping date for ordered production equipment for its cleanroom production
facility at the company's Hubbard, Ohio headquarters. This order consists of
four machines for production of BNP rapid-detection kits and is anticipated
to be the first of many for kit production.
NanoLogix management, staff, and directors would like to congratulate Corporate
Counsel David R. Barnhizer for his recent three-year appointment as Visiting
Professor to the University of Westminster, London. Professor Barnhizer will
continue as corporate counsel.